146 related articles for article (PubMed ID: 15365813)
1. Histological changes of the dopaminergic nigrostriatal system in aging.
Stark AK; Pakkenberg B
Cell Tissue Res; 2004 Oct; 318(1):81-92. PubMed ID: 15365813
[TBL] [Abstract][Full Text] [Related]
2. Age and Parkinson's disease-related neuronal death in the substantia nigra pars compacta.
Eriksen N; Stark AK; Pakkenberg B
J Neural Transm Suppl; 2009; (73):203-13. PubMed ID: 20411779
[TBL] [Abstract][Full Text] [Related]
3. Aging of the nigrostriatal system in the squirrel monkey.
McCormack AL; Di Monte DA; Delfani K; Irwin I; DeLanney LE; Langston WJ; Janson AM
J Comp Neurol; 2004 Apr; 471(4):387-95. PubMed ID: 15022260
[TBL] [Abstract][Full Text] [Related]
4. Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys.
Herzog CD; Dass B; Holden JE; Stansell J; Gasmi M; Tuszynski MH; Bartus RT; Kordower JH
Mov Disord; 2007 Jun; 22(8):1124-32. PubMed ID: 17443702
[TBL] [Abstract][Full Text] [Related]
5. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
[TBL] [Abstract][Full Text] [Related]
6. The dopaminergic nigrostriatal system: development, physiology, disease.
von Bohlen Und Halbach O; Krieglstein K; Schober A; Schulz JB
Cell Tissue Res; 2004 Oct; 318(1):3. PubMed ID: 15340830
[No Abstract] [Full Text] [Related]
7. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat.
González-Hernández T; Barroso-Chinea P; Rodríguez M
Mov Disord; 2004 Sep; 19(9):1029-1042. PubMed ID: 15372592
[TBL] [Abstract][Full Text] [Related]
8. Serum uric acid and clinical progression in Parkinson disease: potential biomarker for nigrostriatal failure.
Schiess M; Oh I
Arch Neurol; 2008 Jun; 65(6):698-9. PubMed ID: 18541788
[No Abstract] [Full Text] [Related]
9. Ageing and the nigrostriatal dopaminergic system.
Reeves S; Bench C; Howard R
Int J Geriatr Psychiatry; 2002 Apr; 17(4):359-70. PubMed ID: 11994891
[TBL] [Abstract][Full Text] [Related]
10. Aging of the rat mesostriatal system: differences between the nigrostriatal and the mesolimbic compartments.
Cruz-Muros I; Afonso-Oramas D; Abreu P; Barroso-Chinea P; Rodríguez M; González MC; Hernández TG
Exp Neurol; 2007 Mar; 204(1):147-61. PubMed ID: 17112516
[TBL] [Abstract][Full Text] [Related]
11. The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.
Hodaie M; Neimat JS; Lozano AM
Neurosurgery; 2007 Jan; 60(1):17-28; discussion 28-30. PubMed ID: 17228250
[TBL] [Abstract][Full Text] [Related]
12. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
Sajadi A; Bauer M; Thöny B; Aebischer P
J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
[TBL] [Abstract][Full Text] [Related]
13. Nigrostriatal interaction in the aging brain: new therapeutic target for Parkinson's disease.
Błaszczyk JW
Acta Neurobiol Exp (Wars); 2017; 77(1):106-112. PubMed ID: 28379221
[TBL] [Abstract][Full Text] [Related]
14. Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats.
Tamás A; Lubics A; Szalontay L; Lengvári I; Reglodi D
Behav Brain Res; 2005 Mar; 158(2):221-9. PubMed ID: 15698888
[TBL] [Abstract][Full Text] [Related]
15. Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice.
Li X; Yin J; Cheng CM; Sun JL; Li Z; Wu YL
Chin Med J (Engl); 2005 Aug; 118(16):1357-61. PubMed ID: 16157030
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of BDNF in young and aged 6-OHDA treated rat model of Parkinson disease.
Singh S; Ahmad R; Mathur D; Sagar RK; Krishana B
Indian J Exp Biol; 2006 Sep; 44(9):699-704. PubMed ID: 16999024
[TBL] [Abstract][Full Text] [Related]
17. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
Gaillard A; Decressac M; Frappé I; Fernagut PO; Prestoz L; Besnard S; Jaber M
Neurobiol Dis; 2009 Sep; 35(3):477-88. PubMed ID: 19616502
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic function and progression of Parkinson's disease: PET findings.
Biju G; de la Fuente-Fernández R
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S38-40. PubMed ID: 20123555
[TBL] [Abstract][Full Text] [Related]
19. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
Carlsson T; Carta M; Muñoz A; Mattsson B; Winkler C; Kirik D; Björklund A
Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
[TBL] [Abstract][Full Text] [Related]
20. The aging striatal dopamine function.
Darbin O
Parkinsonism Relat Disord; 2012 Jun; 18(5):426-32. PubMed ID: 22176812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
